At this year's CES, the colorful Qualcomm booth exhibited a variety of novelty: red dragon robots, blue-connected cars with flashing Qualcomm logo on the roof, and mannequins with various smart watches in the glass case. The venue was full of hustle and bustle, and in a quiet reception room behind the Qualcomm booth, company president Derek Aberle was explaining the Qualcomm 2015 strategy. Qualcomm is currently the world's largest mobile chip maker, and it hopes to further expand its influence in wearables, robotics, automotive, medical technology and other fields. Qualcomm's vision is also the common ideal of other technology vendors - to seize the commanding heights of the Internet of Things. The Internet of Things has shown great potential and attracted many Qualcomm competitors. For example, close to Qualcomm's Intel booth, a variety of networked devices have appeared. According to market research firm IDC, by 2020, the Internet of Things market is expected to reach US$3.04 trillion, which is why many vendors are competing. While Qualcomm is trying to seize all of these new markets, the maker of the Snapdragon mobile chip is experiencing an antitrust investigation from the Chinese authorities. But Bailey said that regardless of the outcome, the impact will not spread to countries and regions outside China. Fully seize the car and medical market Bailey said that in the Internet of Things, automotive and wireless medical care is the focus of Qualcomm. In the automotive sector, the company will further develop on its own networked vehicles, such as the development of OnStar safety and navigation systems with GM, and the introduction of digital display and security system-related products, such as cameras that continuously monitor the driver's face. Notify if the driver is driving fatigued. Qualcomm will face direct competition from display chip maker NVIDIA in the automotive sector, which has already had a significant impact in this area. "The future of the car will be a powerful computer," Nvidia CEO Huang Renxun told hundreds of viewers at CES, he also stressed that the company will provide a new solution for autonomous driving and digital dashboard display technology. In the medical field, Qualcomm announced last week that it will cooperate with chain drugstore giant Walgreens and pharmaceutical giant Swiss Novartis to use its mobile technology advantages to launch a remote patient monitoring system and accelerate data collection for drug testing. . Qualcomm hopes that these technologies will reduce medical costs while providing patients with more convenient services. Bailey said that the company's designed chips for wearable and other connected devices have already begun to ship, not just at the planning stage. In terms of the company's management organization, Bailey said that in the main mobile business, the company has formed a dedicated team, and the company has a dedicated team for each core business in the new field. This move is expected to allow each team to focus on their top priorities without being disturbed by other complicated matters. As the smartphone market matures, Qualcomm needs to find new growth points to maintain its growth rate. The company has partnered with mainstream smartwatch manufacturers including Samsung, Sony and Apple to design smaller and lower power chips. At the same time, the company's $2.5 billion acquisition of the British chip manufacturer CSR will further consolidate Qualcomm's wireless Bluetooth technology, which is one of the key technologies for networked devices. At this point, the company has mastered the advantages of the chip in the field of wearables and the Internet of Things, however, these can not guarantee the ultimate success. Dingmin Pharmaceutical supply Canagliflozin API and Canagliflozin Intermediates with high purity and best price. The main products CAS No are as follows: 842133-18-0, 898566-17-1, 1030825-20-7. Sample can be sent if you request. Cas 842133-18-0,Canagliflozin Intermediates,5-Iodo-2-Methylphenyl Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com
Welcome to do business with us. Please email to us directly.